Håkan Rolf Norell
AuthID: R-004-TZM
1
TITLE: VEGFR2-Mediated Reprogramming of Mitochondrial Metabolism Regulates the Sensitivity of Acute Myeloid Leukemia to Chemotherapy
AUTHORS: Nobrega Pereira, S; Caiado, F; Carvalho, T; Matias, I; Graca, G; Goncalves, LG; Silva Santos, B; Norell, H; Dias, S;
PUBLISHED: 2018, SOURCE: CANCER RESEARCH, VOLUME: 78, ISSUE: 3
AUTHORS: Nobrega Pereira, S; Caiado, F; Carvalho, T; Matias, I; Graca, G; Goncalves, LG; Silva Santos, B; Norell, H; Dias, S;
PUBLISHED: 2018, SOURCE: CANCER RESEARCH, VOLUME: 78, ISSUE: 3
2
TITLE: Intra-tumour heterogeneity - going beyond genetics Full Text
AUTHORS: Francisco Caiado; Bruno Silva Santos; Hakan Norell;
PUBLISHED: 2016, SOURCE: FEBS JOURNAL, VOLUME: 283, ISSUE: 12
AUTHORS: Francisco Caiado; Bruno Silva Santos; Hakan Norell;
PUBLISHED: 2016, SOURCE: FEBS JOURNAL, VOLUME: 283, ISSUE: 12
3
TITLE: γδ T cells in cancer
AUTHORS: Bruno Silva-Santos; Karine Serre; Håkan Norell;
PUBLISHED: 2015, SOURCE: Nat Rev Immunol - Nature Reviews Immunology, VOLUME: 15, ISSUE: 11
AUTHORS: Bruno Silva-Santos; Karine Serre; Håkan Norell;
PUBLISHED: 2015, SOURCE: Nat Rev Immunol - Nature Reviews Immunology, VOLUME: 15, ISSUE: 11
4
TITLE: At the Bench: Preclinical rationale for exploiting NK cells and gamma delta T lymphocytes for the treatment of high-risk leukemias
AUTHORS: Hakan Norell; Alessandro Moretta; Bruno Silva Santos ; Lorenzo Moretta;
PUBLISHED: 2013, SOURCE: JOURNAL OF LEUKOCYTE BIOLOGY, VOLUME: 94, ISSUE: 6
AUTHORS: Hakan Norell; Alessandro Moretta; Bruno Silva Santos ; Lorenzo Moretta;
PUBLISHED: 2013, SOURCE: JOURNAL OF LEUKOCYTE BIOLOGY, VOLUME: 94, ISSUE: 6
5
TITLE: A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice
AUTHORS: Mehrotra, S; Al Khami, AA; Klarquist, J; Husain, S; Naga, O; Eby, JM; Murali, AK; Lyons, GE; Li, M; Spivey, ND; Norell, H; Da Palma, TM; Onicescu, G; Diaz Montero, CM; Garrett Mayer, E; Cole, DJ; Le Poole, IC; Nishimura, MI;
PUBLISHED: 2012, SOURCE: Journal of Immunology, VOLUME: 189, ISSUE: 4
AUTHORS: Mehrotra, S; Al Khami, AA; Klarquist, J; Husain, S; Naga, O; Eby, JM; Murali, AK; Lyons, GE; Li, M; Spivey, ND; Norell, H; Da Palma, TM; Onicescu, G; Diaz Montero, CM; Garrett Mayer, E; Cole, DJ; Le Poole, IC; Nishimura, MI;
PUBLISHED: 2012, SOURCE: Journal of Immunology, VOLUME: 189, ISSUE: 4
6
TITLE: Off-Target Function of the Sonic Hedgehog Inhibitor Cyclopamine in Mediating Apoptosis via Nitric Oxide-Dependent Neutral Sphingomyelinase 2/Ceramide Induction
AUTHORS: Meyers-Needham, M; Lewis, JA; Gencer, S; Sentelle, RD; Saddoughi, SA; Clarke, CJ; Hannun, YA; Norell, H; da Palma, TM; Nishimura, M; Kraveka, JM; Khavandgar, Z; Murshed, M; Cevik, MO; Ogretmen, B;
PUBLISHED: 2012, SOURCE: Molecular Cancer Therapeutics, VOLUME: 11, ISSUE: 5
AUTHORS: Meyers-Needham, M; Lewis, JA; Gencer, S; Sentelle, RD; Saddoughi, SA; Clarke, CJ; Hannun, YA; Norell, H; da Palma, TM; Nishimura, M; Kraveka, JM; Khavandgar, Z; Murshed, M; Cevik, MO; Ogretmen, B;
PUBLISHED: 2012, SOURCE: Molecular Cancer Therapeutics, VOLUME: 11, ISSUE: 5
7
TITLE: T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules Full Text
AUTHORS: Kaur, N; Naga, OS; Norell, H; Al Khami, AA; Scheffel, MJ; Chakraborty, NG; Voelkel Johnson, C; Mukherji, B; Mehrotra, S;
PUBLISHED: 2011, SOURCE: Cytokine, VOLUME: 55, ISSUE: 2
AUTHORS: Kaur, N; Naga, OS; Norell, H; Al Khami, AA; Scheffel, MJ; Chakraborty, NG; Voelkel Johnson, C; Mukherji, B; Mehrotra, S;
PUBLISHED: 2011, SOURCE: Cytokine, VOLUME: 55, ISSUE: 2
8
TITLE: Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: A pilot clinical trial Full Text
AUTHORS: Norell, H; Poschke, I; Charo, J; Wei, WZ; Erskine, C; Piechocki, MP; Knutson, KL; Bergh, J; Lidbrink, E; Kiessling, R;
PUBLISHED: 2010, SOURCE: Journal of Translational Medicine, VOLUME: 8, ISSUE: 1
AUTHORS: Norell, H; Poschke, I; Charo, J; Wei, WZ; Erskine, C; Piechocki, MP; Knutson, KL; Bergh, J; Lidbrink, E; Kiessling, R;
PUBLISHED: 2010, SOURCE: Journal of Translational Medicine, VOLUME: 8, ISSUE: 1
9
TITLE: CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting Full Text
AUTHORS: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLISHED: 2010, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 59, ISSUE: 6
AUTHORS: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLISHED: 2010, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 59, ISSUE: 6
10
TITLE: HER-2/neu mediated down-regulation of MHC class i antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice Full Text
AUTHORS: Vertuani, S; Triulzi, C; Roos, AK; Charo, J; Norell, H; Lemonnier, F; Pisa, P; Seliger, B; Kiessling, R;
PUBLISHED: 2009, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 58, ISSUE: 5
AUTHORS: Vertuani, S; Triulzi, C; Roos, AK; Charo, J; Norell, H; Lemonnier, F; Pisa, P; Seliger, B; Kiessling, R;
PUBLISHED: 2009, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 58, ISSUE: 5
